TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) has 7 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 5 sales totalling $1.5M. Most recent filing: Aug. 25, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 25, 2026 filed Aug. 21, 2026 | Weiss Amir Chief Accounting Officer | −$261,256 | 14,445 | −48% | No | |
|
|
||||||
| Aug. 25, 2026 filed Aug. 21, 2026 | Satchi-Fainaro Ronit Director | −$15,459 | 415 | −0% | No | |
|
|
||||||
| Aug. 19, 2026 filed Aug. 17, 2026 | Lippman Evan EVP, Business Development | −$680,291 | 18,600 | −42% | Yes | |
|
|
||||||
| Aug. 10, 2026 filed Aug. 5, 2026 | Zaks Tal Zvi Director | −$593 | 17 | −0% | No | |
|
|
||||||
| Aug. 5, 2026 filed Aug. 3, 2026 | Jover Placid See "Remarks" | $447,351 | 38,481 | 0% | Yes | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free